
French biotech GenSight has begun enrolling patients for two parallel pivotal Phase III trials with its lead candidate GS010, a …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

